Michael Ezekowitz, MD
Enriched profileProfessor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University; attending cardiologist, Main Line Health · Sidney Kimmel Medical College
Michael Ezekowitz is Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University; attending cardiologist, Main Line Health at Sidney Kimmel Medical College. OpenAlex indexes 380 publications with 73,584 citations (h-index 92); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michael D. Ezekowitz, MD, is Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University. The public record shows 380 publications with 73,584 citations (h-index 92), centered on Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Antiplatelet Therapy and Cardiovascular Diseases. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.
- Most recent indexed publication: 2024 · Journal of the American Heart Association
- Top research focus: Atrial Fibrillation Management and Outcomes
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 223.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
Sponsor: Portola Pharmaceuticals
Industry payments
Updated 27 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20253 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
- Janssen Research & Development, LLCProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
59.7%Statin32.3%Atorvastatin Calcium78%Rosuvastatin Calcium22%Part D<11 patientsLoop diuretic12.8%Furosemide100%Part D<11 patientsBlood & clotting
24.8%Factor Xa inhibitor19.5%Eliquis59%Xarelto41%Part D<11 patientsDirect thrombin inhibitors5.3%Dabigatran Etexilate100%Part D<11 patientsGenitourinary & hormones
5.3%5-alpha Reductase Inhibitor5.3%Dutasteride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.
Journal of the American Heart Association
Meta-analysis2024 - Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
Cardiovascular research
Clinical Trial2022 - Drug Interactions Affecting Oral Anticoagulant Use.
Circulation. Arrhythmia and electrophysiology
Review2022 - Drug Interactions Affecting Antiarrhythmic Drug Use.
Circulation. Arrhythmia and electrophysiology
Review2022
Most-cited works
by citation count (OpenAlex)- 01Dabigatran versus Warfarin in Patients with Atrial Fibrillation11,214 citations2009
- 02
- 03
- 04
- 05Forecasting the Future of Cardiovascular Disease in the United States3,234 citations2011
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michael-ezekowitz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/michael-ezekowitz-93476713
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-D-Ezekowitz-2145373163
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
reachmd.com/profiles/michael-d-ezekowitz-mbchb-dphil-frcp-facc/OYy8zb/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBChB
University of Cape Town Medical School (South Africa)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗ - DPhil (PhD)
Imperial College, University of London
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- Fellow
Royal College of Physicians (FRCP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗ - Fellow
American College of Cardiology (FACC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Postgraduate internship/training
Groote Schuur Hospital, Cape Town
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗ - Fellowship
Johns Hopkins University Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗
Editorial & leadership roles
journal and society appointments- Co-principal investigator
RE-LY trial (dabigatran vs. warfarin for stroke prevention in atrial fibrillation)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Executive committee member
ENGAGE AF-TIMI 48 trial (edoxaban)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hearteducationusa.com ↗
Awards & honors
honors on the public record- First Heart Rhythm Institute Distinguished Visiting Professor
University of Oklahoma Health Science Center
2016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗ - Top 1% Clinical Scientist in the World (Thomson Reuters)
2014 and 2015, based on citation impact of publications
2015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗ - Honorary Master's degree
Yale University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hearteducationusa.com ↗
Secondary affiliations
appointments beyond the home institution- Former Professor and Vice President for Clinical Research
Lankenau Institute for Medical Research
2015provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiobrief.org ↗ - Director of Atrial Fibrillation Research and Education
Cardiovascular Research Foundation (CRF), New York, NY
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - Attending cardiologist
Lankenau Medical Center, Bryn Mawr Hospital, and Paoli Hospital (Main Line Health system)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.